Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$thar](/topic/$thar)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$thar/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$thar/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +3%  
**1-Year High**: XXX% on 2025-04-28  
**1-Year Low**: XX% on 2025-08-12  

**Most Supportive Themes**
- **Positive Clinical Trial Results:** (45%) Positive sentiment around $THAR's potential, driven by the release of positive clinical trial results and FDA fast-track designation for TH104, a drug for opioid overdose.
- **Bullish Sentiment and Recommendations:** (35%) Strong interest from traders and analysts, with many recommending $THAR as a buy and highlighting its potential for significant gains.
- **Association with other high-performing stocks:** (10%) Mentions of $THAR in conjunction with other stocks that have recently seen significant gains, suggesting a broader trend of interest in microcap stocks.
  
**Most Critical Themes**
- **Market Manipulation Concerns:** (10%)  Concerns about potential market manipulation and short selling activities related to $THAR, with mentions of high trading volumes and potential for price drops.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | X        | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$thar

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +3%
1-Year High: XXX% on 2025-04-28
1-Year Low: XX% on 2025-08-12

Most Supportive Themes

  • Positive Clinical Trial Results: (45%) Positive sentiment around $THAR's potential, driven by the release of positive clinical trial results and FDA fast-track designation for TH104, a drug for opioid overdose.
  • Bullish Sentiment and Recommendations: (35%) Strong interest from traders and analysts, with many recommending $THAR as a buy and highlighting its potential for significant gains.
  • Association with other high-performing stocks: (10%) Mentions of $THAR in conjunction with other stocks that have recently seen significant gains, suggesting a broader trend of interest in microcap stocks.

Most Critical Themes

  • Market Manipulation Concerns: (10%) Concerns about potential market manipulation and short selling activities related to $THAR, with mentions of high trading volumes and potential for price drops.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% X X%
Total XXXXX XX% XXXXX XX% X X%
$thar Sentiment
/topic/$thar/sentiment